NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new data presented during the Heart Failure Society of America’s Annual Scientific Meeting focused on the use of Daxor’s BVA-100® blood […]
Tag: Daxor
DAXOR ANNOUNCES PROSPECTIVE RANDOMIZED CONTROL TRIAL AT DUKE UNIVERSITY MEDICAL CENTER TO GUIDE VOLUME TREATMENT IN HEART FAILURE PATIENTS
Enrollment Commences Using the BVA-100® Diagnostic Blood Test NEW YORK, July 16, 2020 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the initiation of a prospective randomized control trial (RTC) utilizing Daxor’s BVA-100 (Blood […]
Recent
Ancora Heart Inc. Reports Two-Year Results Demonstrating Sustained Benefits of AccuCinch® System in Heart Failure Patients
Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman
AngioInsight Appoints Medtech Veteran Shlomi Nachman to Board of Directors; Announces Series A Round to Accelerate AI-Driven Advancement in Cardiology
Popular
- No commented posts yet